Key facts
- It has raised $52.5M; the latest was Later Stage VC ($28.1M) in Sep 2025.
- Notable investors include StartLife, Brabantse Ontwikkelings Maatschappij, Invest-NL (Investment Company), Oost NL, Thematic Technology Transfer — 14 tracked in total.
- revyve has filed 1 Form D with the SEC, most recently Nov 2014 ($40K sold to 26 investors).
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for revyve
- ·The full record, as it builds
Funding rounds
No funding rounds for revyve are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About revyve
Operator of a purpose-driven food-tech company intended to create replacement proteins from microorganisms. The company specializes in ingredients for the production of animal-free food that can be used as egg replacers prepared using natural microorganisms, enabling customers to enjoy great-tasting foods without compromising on taste, texture, health, or sustainability.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Wageningen, Netherlands
- Founded
- 2019
- Employees
- 38
- Website
- revyve.bio/
- Ownership
- Privately Held (backing)
revyve doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in revyve shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on revyve in its N-PORT filings yet. We sweep new filings monthly.